Maravai climbs on collaboration to launch DNA concentration testing kit

Maravai Lifesciences Holdings

28/08/2024 13:31

** Shares of diagnostics co Maravai LifeSciences  MRVI.O 
rise ~2.8% to $9.28 premarket
    ** Co says Cygnus Technologies and TriLink BioTechnologies,
both part of Maravai, have collaborated to launch AccuRes host
cell DNA quantification kits
    ** The kits determine concentration of DNA in a sample and
helps to produce safe and stable vaccines and therapies 
    ** Up to last close, stock was up 37.9% YTD

    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))